ELMIRON® is the only FDA-approved oral medication for the treatment of bladder pain or discomfort associated with IC







ELMIRON® provides proven efficacy and sustained pain relief over time.2 Symptom relief is often gradual, and clinical response may require up to 6 months of therapy. In patients whose pain has not improved after 6 months of therapy, the clinical relevance and risks of continued treatment are unknown. ELMIRON® is also generally well tolerated. In a 32-week study (n=128), 3 out of 4 patients reported that they would recommend ELMIRON® to other patients with IC.*3

*This value includes 128 IC patients in a randomized, double-blind, 32-week study receiving ELMIRON® 300 mg/day.

    References:
  1. Forrest JB. Epidemiology and quality of life. J Reprod Med. 2006;51(suppl):227-233.
  2. Hanno PM. Analysis of long-term Elmiron therapy for interstitial cystitis. Urology. 1997;49(suppl 5A):93-99.
  3. Sand PK, Zhang HF, Chen A, Creanga DL, Wan GJ. Association between symptom reduction and satisfaction with pentosan polysulfate sodium in subjects with interstitial cystitis. Poster presented at: American College of Obstetricians and Gynecologists Districts III, VI, VIII, & IX Annual Meeting; November 8-11, 2006; Kohala Coast, HI.